These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 8494718)
1. Antisense technology for cancer therapy: does it make sense? Carter G; Lemoine NR Br J Cancer; 1993 May; 67(5):869-76. PubMed ID: 8494718 [No Abstract] [Full Text] [Related]
3. Antisense tumor therapy (a dream under construction). Kopper L; Kovalszky I In Vivo; 1994; 8(5):781-6. PubMed ID: 7727725 [TBL] [Abstract][Full Text] [Related]
4. Making sense of antisense. Murakami A Trends Mol Med; 2001 Oct; 7(10):430-1. PubMed ID: 11597507 [No Abstract] [Full Text] [Related]
5. [The application of antisense technology in ophthalmology]. Guo Y; Ge J Yan Ke Xue Bao; 1998 Jun; 14(2):108-15. PubMed ID: 12580046 [TBL] [Abstract][Full Text] [Related]
6. Antisense DNA and RNA strategies: new approaches to therapy. Gibson I J R Coll Physicians Lond; 1994; 28(6):507-11. PubMed ID: 7884705 [TBL] [Abstract][Full Text] [Related]
7. Molecular therapeutic strategies in hepatitis B virus infection. Offensperger WB; Blum HE; Gerok W Clin Investig; 1994 Oct; 72(10):737-41. PubMed ID: 7865975 [TBL] [Abstract][Full Text] [Related]
8. Antisense and sensibility. Dove A Nat Biotechnol; 2002 Feb; 20(2):121-4. PubMed ID: 11821852 [No Abstract] [Full Text] [Related]
9. Antisense strategies in degenerative joint diseases: sense or nonsense? Huber LC; Distler O; Gay RE; Gay S Adv Drug Deliv Rev; 2006 May; 58(2):285-99. PubMed ID: 16574269 [TBL] [Abstract][Full Text] [Related]
10. Antisense DNA and RNA agents against picornaviruses. Lim T; Yuan J; Zhang HM; Sall A; Liu Z; Su Y; Yang D Front Biosci; 2008 May; 13():4707-25. PubMed ID: 18508540 [TBL] [Abstract][Full Text] [Related]
11. Utility of antioncogene ribozymes and antisense oligonucleotides in reversing drug resistance. Funato T Methods Mol Med; 2005; 106():215-33. PubMed ID: 15375319 [No Abstract] [Full Text] [Related]
12. Gene therapy for HIV. Lever AM Sex Transm Infect; 2001 Apr; 77(2):93-6. PubMed ID: 11287684 [No Abstract] [Full Text] [Related]
13. RNA as a target for developing antivirals. McKnight KL; Heinz BA Antivir Chem Chemother; 2003 Mar; 14(2):61-73. PubMed ID: 12856917 [TBL] [Abstract][Full Text] [Related]
14. DNA combination therapy to stop tumor growth. Wickstrom E; Smith JB Cancer J Sci Am; 1998 May; 4 Suppl 1():S43-7. PubMed ID: 9619270 [No Abstract] [Full Text] [Related]
15. Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents. Rossi JJ; Sarver N Adv Exp Med Biol; 1992; 312():95-109. PubMed ID: 1514448 [No Abstract] [Full Text] [Related]
16. Therapeutic antisense and ribozymes. Rossi JJ Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645 [TBL] [Abstract][Full Text] [Related]
17. Antisense approaches to cancer gene therapy. Mercola D; Cohen JS Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254 [TBL] [Abstract][Full Text] [Related]
18. Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents. Rossi JJ; Elkins D; Taylor N; Zaia J; Sullivan S; Deshler JO Antisense Res Dev; 1991; 1(3):285-8. PubMed ID: 1821650 [TBL] [Abstract][Full Text] [Related]
19. Therapies that make sense. Akhtar S; Ivinson AJ Nat Genet; 1993 Jul; 4(3):215-7. PubMed ID: 8358426 [No Abstract] [Full Text] [Related]
20. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses. Alvarez-Salas LM; BenÃtez-Hess ML; DiPaolo JA Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]